Dailey, G E <br/><br/>
Empagliflozin: a new treatment option for patients with type 2 diabetes mellitus.  [electronic resource] 

 -  Drugs of today (Barcelona, Spain : 1998)  Sep 2015 
 - 519-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1699-3993 
<br/><br/><label>Standard No.: </label>10.1358/dot.2015.51.9.2368554  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzhydryl Compounds--adverse effects<br/>Biomarkers--blood<br/>Blood Glucose--drug effects<br/>Diabetes Mellitus, Type 2--blood<br/>Glucosides--adverse effects<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Kidney Tubules, Proximal--drug effects<br/>Renal Elimination--drug effects<br/>Sodium-Glucose Transporter 2--metabolism<br/>Sodium-Glucose Transporter 2 Inhibitors<br/>Treatment Outcome